New treatments

More young adults are getting bowel cancer. Is Switzerland screening too late?

Microscope screen of a colon cancer cell.

This content was published on Dec 10, 2025 Colorectal cancer rates are growing among the under-50. When is the right time to scan?

Research frontiers

Your questions answered: Are there alternatives to antibiotics?

This content was published on Nov 20, 2025 Readers asked us a host of questions about rising resistance to antibiotics. We have some answers.

Female patient lying in hospital bed (KEYSTONE/PHOTOALTO "S/Michele Constantini)

Medicine access

Under-50s cancer patients face system unprepared for them

This content was published on Nov 17, 2025 Countries, including Switzerland, are struggling to deal with the challenges posed by rising cancer rates among people under 50.

Geneva University Hospitals performing organ transplant

Healthcare innovation

Geneva hospital does partial heart transplant in a first for Europe

This content was published on Oct 16, 2025 The Geneva University Hospitals have performed the first partial heart transplant in Europe, on a 12-year-old patient suffering from complex congenital heart disease.

Medicine access

Patent battle in India tests Roche’s grip on rare disease market

This content was published on Oct 16, 2025 What's behind the patent battle between an Indian generic maker and Roche over a rare disease drug?

Swiss researchers develop corneal implant from 3D printer

Healthcare innovation

Swiss researchers eye 3D printed corneal implants

This content was published on Oct 14, 2025 Swiss researchers plan to use 3D printers to produce artificial corneas.

Roche, US also gives green light for innovative Alzheimer's test

Healthcare innovation

Roche gets US green light for innovative Alzheimer’s test

This content was published on Oct 13, 2025 Roche gets FDA approval for novel Alzheimer's test treatment.

As private equity firms expand their footprint into the world of pharmaceuticals testing, many drug trials are now being vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and patient safety.

Healthcare innovation

How private equity oversees the ethics of drug research

This content was published on Oct 7, 2025 Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and patient safety.

Roche claims clinical success against breast cancer

New treatments

Roche claims success against breast cancer in phase III clinical trials

This content was published on Sep 22, 2025 Roche has achieved positive results from the phase III evERA study combining its experimental treatments giredestrant and everolimus against a specific form of breast cancer.

Drug pricing

How a clash with Roche exposed cracks in Swiss drug pricing system

This content was published on Sep 19, 2025 Switzerland’s new process to speed up patient access to the latest drugs hit its first major hurdle in a clash with Roche.

New treatments

Popular Stories

Most Discussed